Picture of Merck & Co logo

MRK Merck & Co Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue39,12141,51848,70459,28360,115
Cost of Revenue
Gross Profit28,06129,93535,46342,07744,200
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses31,82136,54536,16641,33858,333
Operating Profit7,3004,97312,53817,9451,783
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes7,1715,86313,87916,4441,889
Provision for Income Taxes
Net Income After Taxes5,6064,52312,35814,526377
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income9,8437,06713,04914,519365
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income9,8437,06713,04914,519365
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS3.964.76.817.891.37
Dividends per Share